TORONTO, Jan. 31, 2019 - ACTO Technologies Inc. emerged as a leader in life sciences commercialization by closing a strong calendar year 2018 with 184% revenue growth and a doubled custome
r base. This past year, ACTO secured global, innovative pharmaceutical, medical d...